Health care stocks were declining late Thursday afternoon, with the NYSE Health Care Index and the Health Care Select Sector SPDR Fund (XLV) both fractionally lower.
The iShares Biotechnology ETF (IBB) rose 0.4%.
In corporate news, Pfizer (PFE) is collaborating with Atavistik Bio to accelerate the discovery of new precision allosteric therapeutics, Atavistik said. Pfizer shares added 0.5%.
BioNexus Gene Lab (BGLC) shares soared 45%. The company said that it was granted temporary exception until May 1 to regain compliance with Nasdaq's minimum bid price rule.
NRX Pharmaceuticals (NRXP) shares surged 35%. The company's Hope Therapeutics unit plans to acquire the Kadima Neuropsychiatry Institute.
Neumora Therapeutics (NMRA) shares plunged past 81% after a phase 3 trial of navacaprant to treat major depressive disorder failed to meet the primary endpoint.
免责声明：投资有风险，本文并非投资建议，以上内容不应被视为任何金融产品的购买或出售要约、建议或邀请，作者或其他用户的任何相关讨论、评论或帖子也不应被视为此类内容。本文仅供一般参考，不考虑您的个人投资目标、财务状况或需求。TTM对信息的准确性和完整性不承担任何责任或保证，投资者应自行研究并在投资前寻求专业建议。